Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 AUD | +0.28% | +3.44% | +14.97% |
02-23 | MyState Posts Lower H1 FY24 Profit, Revenue | MT |
02-23 | Transcript : MyState Limited, H1 2024 Earnings Call, Feb 23, 2024 |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.97% | 266M | C+ | ||
+17.30% | 573B | C+ | ||
+17.76% | 310B | C+ | ||
+24.61% | 258B | C+ | ||
+24.87% | 214B | C | ||
+26.67% | 190B | B- | ||
+32.89% | 174B | B- | ||
+10.40% | 331B | C+ | ||
+7.86% | 150B | B- | ||
+8.68% | 136B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MYS Stock
- Ratings MyState Limited